Ignite Creation Date:
2024-05-05 @ 10:34 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01134328
Status:
COMPLETED
Last Update Posted:
2017-09-14
First Post:
2010-05-28
Brief Title:
Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC Model
Sponsor:
Aciex Therapeutics Inc
Organization:
Aciex Therapeutics Inc
Study Overview
Official Title:
A Multi-Center Randomized Double-Masked Evaluation of the Efficacy of Cetirizine 01Fluticasone 0005 Ophthalmic Solution Compared to Its Components and Vehicle in a Modified Conjunctival Allergen Challenge CAC Model During Pollen Season
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CAC Model
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None